http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111423377-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111423377-B |
| titleOfInvention | 5-amino-1H-pyrazole derivative, preparation method and medical application |
| abstract | The invention discloses a 5-amino-1H-pyrazole derivative shown as a general formula (I) or a pharmaceutically acceptable salt thereof, a preparation method thereof and a compound serving as P2Y 14 Use of a receptor inhibitor. Compared with the prior art, the invention discloses a pair P2Y 14 5-amino-1H-pyrazole derivatives with receptor inhibiting effect and pharmaceutically acceptable salts thereof, and the compounds are proved to be P2Y through pharmacological experiments 14 The receptor has obvious inhibiting effect, and can be particularly used as a medicament for treating inflammatory diseases. |
| priorityDate | 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.